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Acetohydroxyacid synthase (AHAS; E.C. 4.1.3.18) is the ®rst enzyme
in the biosynthetic pathway of the branched-chain amino acids
isoleucine, leucine and valine. It is a thiamin diphosphate-dependent
enzyme which catalyses the decarboxylation of pyruvate and its
condensation with either 2-ketobutyrate or a second molecule of
pyruvate to give 2-aceto-2-hydroxybutyrate or 2-acetolactate, respec-
tively. The enzyme is the target of sulfonylurea and imidazolinone
herbicides, which act as potent and speci®c inhibitors. Here, the
crystallization and preliminary X-ray diffraction analysis of the
catalytic subunit of Saccharomyces cerevisiae AHAS is reported.
Data to 2.7 AÊ resolution have been collected using synchrotron
radiation (Advanced Photon Source, Chicago). Crystals have unit-
cell parameters a = 95.8, b = 110.0, c = 178.9 AÊ and belong to the space
group P212121. Preliminary analysis indicates there is one dimer
located in each asymmetric unit.
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1. Introduction
Acetohydroxyacid synthase (AHAS; E.C.
4.1.3.18; reviewed by Duggleby & Pang, 2000),
also known as acetolactate synthase, catalyses
the decarboxylation of pyruvate and its
condensation with either 2-ketobutyrate or a
second molecule of pyruvate to give 2-aceto-2-
hydroxybutyrate or 2-acetolactate, respectively
(Gollop et al., 1989). The product 2-aceto-
lactate is a precursor molecule used in the
biosynthesis of valine and leucine, while
2-aceto-2-hydroxybutyrate is the precursor for
isoleucine. AHAS belongs to a homologous
family of enzymes that cleave a carbon±carbon
bond adjacent to a carbonyl group using
thiamin diphosphate (ThDP) as a cofactor. In
addition to ThDP, which participates directly in
catalysis, AHAS requires two other cofactors:
a divalent metal ion that is thought to anchor
ThDP to the enzyme and ¯avin adenine di-
nucleotide (FAD), the function of which is
unknown. Interest in AHAS has been stimu-
lated by the fact that this enzyme is the target
for several diverse families of herbicides,
including sulfonylureas, imidazolinones, tri-
azolopyrimidines and pyriminidinyl oxyben-
zoates.
It is generally agreed that the bacterial
enzyme functions as a multimeric protein. In
Escherichia coli and Salmonella typhimurium,
three isozymes of AHAS have been observed
and all are tetramers consisting of two catalytic
subunits (60 kDa) and two regulatory sub-
units (9±17 kDa). The catalytic subunit alone
shows low (Weinstock et al., 1992; Vyazmensky
et al., 1996) or no activity (Hill et al., 1997) and
is greatly stimulated by reconstitution with the
regulatory subunit. Moreover, the recon-
stituted enzyme acquires sensitivity to feed-
back inhibition by valine. In contrast, a
regulatory subunit has never been observed for
the enzyme isolated from eukaryotes, although
the existence of such a subunit has been
inferred from other evidence (Duggleby, 1997).
In 1999, we showed that the open reading
frame YCL009c corresponds to the yeast
AHAS regulatory subunit and that combining
the two puri®ed yeast subunits in concentrated
phosphate and neutral pH increased the cata-
lytic activity sevenfold compared with the
catalytic subunit alone (Pang & Duggleby,
1999). The stimulated activity is sensitive to
valine inhibition and this inhibition is reversed
by ATP. Later work elsewhere (Hershey et al.,
1999) identi®ed a putative tobacco AHAS
regulatory subunit and we have described the
Arabidopsis thaliana equivalent (Lee &
Duggleby, 2001). It now seems likely that such
subunits are a common feature of AHAS from
all species.
No experimentally determined structure of
AHAS from any source has been reported.
However, the structures of several ThDP-
dependent enzymes are known, including
Lactobacillus plantarum pyruvate oxidase
(POX; Muller & Schulz, 1993), Pseudomonas
putida benzoylformate decarboxylase (BFD;
Hasson et al., 1998), pyruvate decarboxylase
from S. uvarum (Dyda et al., 1993), S. cerevisiae
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(Arjunan et al., 1996) and Zymomonas
mobilis (Dobritzsch et al., 1998), S. cerevisiae
transketolase (Lindqvist et al., 1992; Nikkola
et al., 1994), the E1 component of the
branched-chain 2-ketoacid dehydrogenase
complex from P. putida (ávarsson et al.,
1999) and Homo sapiens (ávarsson et al.,
2000) and Desulfovibrio africanus pyruvate:
ferredoxin oxidoreductase (ChabrieÁ re et al.,
1999). Several of these enzymes exhibit
weak homology (up to 30% identity) with
the catalytic subunit of AHAS, but none of
them contain a homologue of the AHAS
regulatory subunit. Two homology models
for the catalytic subunit of AHAS, based on
POX, have been constructed (Ott et al.,
1996; Ibdah et al., 1996) and these models
have been useful in predicting speci®c resi-
dues involved in catalysis and herbicide
binding. Recently, tentative models of the
AHAS regulatory subunit have been
described (Mendel et al., 2001; Lee &
Duggleby, 2001).
Determination of the structure of AHAS
will elucidate the geometrical arrangement
of the catalytically important residues in the
active site and de®ne the structure of the
herbicide inhibitor-binding site. Clues to the
catalytic mechanism, the control of substrate
speci®city, the role of FAD, the mode of
action of the regulatory subunit and the
mechanism of regulation by valine and ATP
and ideas as to how improved AHAS inhi-
bitors could be developed should also
emerge once the structure is known. In this
study, we have crystallized the catalytic
subunit of S. cerevisiae AHAS in the
presence of the three cofactors, Mg2+, ThDP
and FAD.
2. Materials and methods
2.1. Expression, purification and
preparation
Construction of the expression vector
(pET.YLSU) used in the production of the
catalytic subunit of AHAS has been
described previously (Pang & Duggleby,
1999). The catalytic subunit of AHAS was
expressed in E. coli strain BL21 (DE3) cells,
which were transformed, induced and
harvested as described previously (Pang &
Duggleby, 1999). Cell lysis and puri®cation
of the expressed 6His-tagged protein was
by immobilized metal af®nity chromato-
graphy (IMAC) as described previously
(Pang & Duggleby, 1999), except that after
the elution of the catalytic subunit from the
IMAC column suf®cient potassium phos-
phate solution pH 6.0 was added to the
active fractions to give a ®nal concentration
of 0.2 M. The molecular weight of the
expressed and puri®ed construct was deter-
mined by mass spectrometry to be
73 518 Da. This value corresponds to that
expected for the recombinant catalytic
subunit of AHAS after removal of the
mitochondrial transit peptide, a 5 kDa
fusion protein containing the 6His tag and
one water molecule. The ®rst crystallization
trials were set up with this material, but
yielded only small poorly diffracting crystals.
To improve the quality of the crystals, an
additional gel-®ltration puri®cation step was
performed using a Superdex HR10/30 size-
exclusion FPLC column. The catalytic
subunit of AHAS was eluted in buffer that
contained 0.2 M potassium phosphate pH
6.0, 1 mM DTT and 10 mM FAD. For long-
term storage, the catalytic subunit of AHAS
was concentrated to 12±20 mg mlÿ1 and
transferred to a buffer containing 0.2 M
potassium phosphate pH 6.0, 10 mM FAD
and 1 mM DTT before being divided into
aliquots of 100 ml and ¯ash-frozen in liquid
nitrogen.
2.2. Crystallization and data collection
Crystallization trials were performed
using the hanging-drop vapour-diffusion
method at 293 K. The search for suitable
crystallization conditions was carried out
using Hampton Crystal Screens I and II.
Crystallization conditions were re®ned by
application of the grid-screen approach
(Bergfors, 1999). Before each crystallization
experiment, the three cofactors and DTT
were added to the freshly thawed enzyme
aliquot to give ®nal concentrations of 1 mM
ThDP, 1 mM MgCl2, 1 mM FAD
and 5 mM DTT. Optimal crystal
growth was obtained by
combining 1 ml of the catalytic
subunit of AHAS with 1 ml of
reservoir solution. The reservoir
solution consisted of 14% PEG
4000, 0.25±0.3 M potassium
phosphate pH 5.8 and 0.2 M
ammonium acetate. The crystals
that appear within 3±4 d are
yellow (owing to the bound FAD
cofactor) and prismatic in shape
and take 14 d to reach their
maximum size.
Preliminary X-ray studies on
these crystals at room tempera-
ture using a rotating-anode
generator showed diffraction to
3.2 AÊ resolution. However, the
diffraction intensity of the crys-
tals decreased quickly after the
initial exposure to X-rays. To
overcome this problem, we developed a
cryocooling strategy, which involves transfer
of the crystals to reservoir solution that has
15%(v/v) glycerol added for cryoprotection.
Crystals were stable in this solution for at
least 0.5 h, showing no signs of cracking or
dissolving.
A complete data set for the AHAS cata-
lytic subunit crystals was collected using a
wavelength of 1.0 AÊ on beamline 14C at the
Advance Photon Source in the Argonne
National Laboratory, Chicago, USA. Data
images were recorded on a Q4 CCD
detector positioned 225 mm from the
crystal. Each oscillation frame was 0.3 in
width and was exposed for 20 s. The
diffraction data were processed to 2.7 AÊ
resolution using the program DENZO
(Otwinowski & Minor, 1997) and were
scaled with the program SCALEPACK
(Otwinowski & Minor, 1997). Analysis of
the X-ray diffraction pattern and averaging
of equivalent intensities allowed character-
ization of the Laue symmetry.
Figure 1
Two crystals of the catalytic subunit of AHAS. The
larger one has dimensions of 0.5  0.2  0.2 mm.
Figure 2
A 0.3 oscillation frame of a cryocooled crystal of the catalytic
subunit of AHAS. Diffraction data are observed to 2.7 AÊ
resolution.
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3. Results and discussion
The initial series of crystallization trials on
the catalytic subunit of AHAS gave drops
that contained numerous nucleation sites,
resulting in the production of small poorly
diffracting crystals. The stored protein is
very stable but the IMAC puri®cation
procedure would not separate active from
inactive AHAS. To solve this problem, an
additional gel-®ltration step was added to
the puri®cation procedure. This had the
effect of removing inactive protein from the
concentrated solution. Using the standard
assay procedure, the speci®c activity of this
highly puri®ed enzyme was 5.0 U mgÿ1
compared with 2.5 U mgÿ1 before gel ®ltra-
tion. Large diffraction-quality crystals of the
catalytic subunit of AHAS could now be
obtained.
The largest crystals of the catalytic
subunit of AHAS have dimensions of
0.5  0.2  0.2 mm (Fig. 1), diffract to 2.7 AÊ
resolution (Fig. 2), have unit-cell parameters
a = 95.8, b = 110.0, c = 178.9 AÊ and belong to
the space group P212121. The mosaic spread
of these crystals at room temperature is
0.23 and increases to 0.35 at 100 K. The
volume of the unit cell is 1.885  106 AÊ 3.
Assuming there is one dimer (147 kDa) in
the asymmetric unit, the Matthews coef®-
cient (Matthews, 1968) VM is 3.62 AÊ
3 Daÿ1.
Based on a value of 0.74 cm3 gÿ1 for the
partial speci®c volume of the protein, the
calculated solvent content is 66.1%. Both
the Matthews coef®cient and solvent
content are well within the normal range
expected for protein crystals (Matthews,
1968). An excellent data set to 2.7 AÊ reso-
lution that has an overall completeness of
95.9% and an Rsym of 0.043 (Table 1) has
been obtained. The placement of the helium
path between the crystal and the beam
restricted the measurement of data to 2.7 AÊ .
However, given the high hIi/h(I)i value of
13.6 for the outer shell of data, it will in the
future be possible to collect signi®cantly
higher resolution data for these crystals.
The crystal structure is currently being
determined by molecular-replacement tech-
niques. Monomers and dimers of the cata-
lytic subunits of POX, BFD and a model of
the catalytic subunit of E. coli AHAS II
(Ibdah et al., 1996) were all tested as search
probes using the program AMoRe (Navaza,
1994). A monomeric model that consists of
residues 9±161 (-domain) and 382±521
(-domain) from BFD was successful in
®nding two independent peaks in the rota-
tion search and translation function.
Combining these two solutions yielded a
plausible dimeric structure. Closer inspec-
tion of the two solutions using the graphics
program O (Jones et al., 1991) did not reveal
any interpenetration of symmetry-related
molecules and showed reasonable crystal
packing contacts. The initial R factor for this
solution was 0.537 using data in the resolu-
tion range 8±4 AÊ ; the structure is currently
being re®ned.
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Table 1
Data-collection statistics for the catalytic subunit of
AHAS.
Values in parentheses are statistics for the 2.81±2.70 AÊ
resolution shell.
Temperature (K) 100
Resolution range (AÊ ) 100.0±2.70
Total No. of observations [I > 0(I)] 188597 (12439)
No. of unique re¯ections [I > 0(I)] 49759 (4649)
Completeness (%) 95.9 (81.7)
Rsym² 0.043 (0.126)
hIi/h(I)i 22.6 (13.6)
² Rsym =
P jI ÿ hIij/PhIi, where I is the intensity of an
individual measurement of each re¯ection and hIi is the mean
intensity of that re¯ection.
